Ann: Change in substantial holding, page-93

That's correct your right.

What I was trying to say there is our FDA dealings could go on for 2 years. Could be 2 years, shorter or longer before being FULLY approved.

Will the Telehealth companies still be lining up as soon as 2H 2017 if we are approved only for use in diagnosing pneumonia in pediatrics? Or would they wait and see the results of our further dealings with the FDA.

These are all relevant balanced questions and discussions I'll be having with the board in Melbourne @ the end of the month. We should hopefully by then, be aware that we are fully loaded on the smartcough-c patient sample.